From October 27, 2021 to December 31, 2021, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on October 29, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.83 CNY | +1.18% | +4.13% | -10.77% |
Apr. 26 | BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.77% | 2.25B | |
-19.60% | 10.94B | |
+64.70% | 3.75B | |
-31.09% | 2.27B | |
-26.86% | 1.54B | |
+35.42% | 1.18B | |
-2.40% | 754M | |
-35.10% | 469M | |
+14.91% | 340M | |
+14.40% | 224M |
- Stock Market
- Equities
- 300676 Stock
- News BGI Genomics Co., Ltd.
- Tranche Update on BGI Genomics Co., Ltd.'s Equity Buyback Plan announced on October 29, 2021.